UPDATED 20.02.2014 13:01

Organised cervical cancer screening programme in Finland in the invitation year 2005. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 427 municipalities (out of 432).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 176504 1356 0.77 12 0.01 2 0.00 40 0.02 124 0.07 196 0.11 182 0.10 800 0.45
I 165229 3 0.00 - - - - - - - - - - - - 3 0.00
II 9921 109 0.06 1 0.00 - - - - - - 3 0.00 5 0.00 100 0.06
III 1154 1154 0.65 4 0.00 1 0.00 23 0.01 90 0.05 181 0.10 171 0.10 684 0.39
IV 88 88 0.05 7 0.00 1 0.00 16 0.01 33 0.02 12 0.01 6 0.00 13 0.01
V 2 2 0.00 - - - - 1 0.00 1 0.00 - - - - - -
Inadequate 110 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 16251 237 1.46 1 0.01 1 0.01 - - 21 0.13 56 0.34 31 0.19 127 0.78
Negative1 14685 10 0.06 - - - - - - - - - - - - 10 0.06
Positive2 1566 227 1.40 1 0.01 1 0.01 - - 21 0.13 56 0.34 31 0.19 117 0.72
Total 192755 1593 0.83 13 0.01 3 0.00 40 0.02 145 0.08 252 0.13 213 0.11 927 0.48

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.